Azenta, Inc. $AZTA Holdings Raised by Jump Financial LLC

Key Points

• Jump Financial LLC increased its stake in Azenta, Inc. by 98.1% during the 1st quarter, holding 46,952 shares valued at approximately $1.63 million.
• Azenta, Inc. reported quarterly earnings of $0.19 per share, beating the consensus estimate of $0.13, with revenues of $143.94 million.
• Analysts have issued mixed ratings for Azenta stock, with a consensus target price of $35.75, including two "Buy" and three "Hold" ratings.

Jump Financial LLC raised its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 98.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 46,952 shares of the company's stock after purchasing an additional 23,249 shares during the period. Jump Financial LLC owned 0.10% of Azenta worth $1,626,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC increased its holdings in Azenta by 788.1% in the first quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock valued at $33,000 after buying an additional 859 shares during the last quarter. Quarry LP bought a new stake in shares of Azenta in the 4th quarter valued at approximately $110,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of Azenta by 13,184.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,524 shares of the company's stock valued at $87,000 after acquiring an additional 2,505 shares during the last quarter. Deutsche Bank AG lifted its stake in Azenta by 28.5% during the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after purchasing an additional 931 shares during the last quarter. Finally, Alpine Global Management LLC bought a new position in Azenta during the fourth quarter worth $218,000. Institutional investors own 99.08% of the company's stock.

Azenta Trading Up 2.1%

NASDAQ:AZTA traded up $0.62 during mid-day trading on Monday, hitting $30.54. The stock had a trading volume of 437,306 shares, compared to its average volume of 716,048. The stock has a market capitalization of $1.40 billion, a price-to-earnings ratio of -12.62 and a beta of 1.65. The company has a 50 day simple moving average of $31.37 and a 200-day simple moving average of $31.97. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $55.63.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06. The firm had revenue of $143.94 million during the quarter, compared to analysts' expectations of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. Azenta's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.14 EPS. As a group, equities research analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AZTA has been the topic of a number of recent research reports. Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. Raymond James Financial raised shares of Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 price objective for the company in a research report on Wednesday, August 6th. Evercore ISI set a $33.00 target price on shares of Azenta and gave the stock an "in-line" rating in a report on Tuesday, August 5th. Finally, Stephens started coverage on Azenta in a report on Tuesday, July 22nd. They set an "equal weight" rating and a $35.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $35.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.